Louise Frederika Kooij, Chief Accounting Officer at NewAmsterdam Pharma Co N.V. (NAMS), sold 72,428 shares at $32.62 ($2.3M) on 2026-01-27, disclosed to the SEC on 2026-01-29.
Open-market sale of $2.3M NAMS by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.62 | 39,816 | $1.3M | 55.6% |
| 2 | $31.80 | 32,612 | $1.0M | 44.4% |
| Total | $32.25 avg | 72,428 | $2.3M | 100% |
| Filing → |
| NAMS | SELL | 2026-05-27 | $2.3M | — | Filing → |
| NAMS | SELL | 2026-01-27 | $2.4M | — | Filing → |
| NAMS | SELL | 2026-01-07 | $88K | — | Filing → |